Cargando…

Efficacy and Safety of Controlled Ovarian Stimulation With or Without Letrozole Co-administration for Fertility Preservation: A Systematic Review and Meta-Analysis

Background: The co-administration of letrozole during controlled ovarian stimulation (COS) with gonadotropins is used to limit the potentially harmful effects of a supra-physiological rise in estrogen levels on hormone-sensitive cancers. However, the efficacy and safety of adding letrozole to COS re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonardi, Benedetta, Massarotti, Claudia, Bruzzone, Marco, Goldrat, Oranite, Mangili, Giorgia, Anserini, Paola, Spinaci, Stefano, Arecco, Luca, Del Mastro, Lucia, Ceppi, Marcello, Demeestere, Isabelle, Lambertini, Matteo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575927/ https://www.ncbi.nlm.nih.gov/pubmed/33117711 http://dx.doi.org/10.3389/fonc.2020.574669

Ejemplares similares

Circulating Tumor DNA to Interrogate the Safety of Letrozole-Associated Controlled Ovarian Stimulation for Fertility Preservation in Breast Cancer Patients
por: Rothé, Françoise, et al.
Publicado: (2021)

Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis
por: Arecco, L, et al.
Publicado: (2022)

The PREgnancy and FERtility (PREFER) Study Investigating the Need for Ovarian Function and/or Fertility Preservation Strategies in Premenopausal Women With Early Breast Cancer
por: Blondeaux, Eva, et al.
Publicado: (2021)

Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers
por: Goldrat, Oranite, et al.
Publicado: (2019)

How I perform fertility preservation in breast cancer patients
por: Razeti, M.G., et al.
Publicado: (2021)

Long-acting gonadotropin-releasing hormone agonist trigger in fertility preservation cycles before chemotherapy
por: Massarotti, C., et al.
Publicado: (2023)

Gender-specific aspects related to type of fertility preservation strategies and access to fertility care
por: Perachino, Marta, et al.
Publicado: (2020)

Impact of Breast Cancer and Germline BRCA Pathogenic Variants on Fertility Preservation in Young Women
por: Prokurotaite, Elze, et al.
Publicado: (2023)

The impact of letrozole administration on oocyte morphology in breast cancer patients undergoing fertility preservation
por: Bercaire, Ludmila M.N., et al.
Publicado: (2020)

The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients
por: Lambertini, Matteo, et al.
Publicado: (2017)

How to Protect Ovarian Function before and during Chemotherapy?
por: Arecco, Luca, et al.
Publicado: (2021)

Cancer and fertility preservation: international recommendations from an expert meeting
por: Lambertini, Matteo, et al.
Publicado: (2016)

Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis
por: Poggio, Francesca, et al.
Publicado: (2018)

ESHRE guideline: female fertility preservation
por: Anderson, Richard A, et al.
Publicado: (2020)

Re: Safety and efficacy concerns of long-acting GnRH agonist trigger for ovulation induction in oncological patients undergoing oocyte cryopreservation: a call for caution and further investigation
por: Massarotti, C., et al.
Publicado: (2023)

Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients
por: Sonigo, Charlotte, et al.
Publicado: (2019)

Fertility Preservation in Female Cancer Patients
por: Demeestere, I., et al.
Publicado: (2012)

Gonadotropin Releasing Hormone Agonists Have an Anti-apoptotic Effect on Cumulus Cells
por: Scaruffi, Paola, et al.
Publicado: (2019)

Fertility preservation in female cancer patients: a single center experience
por: Sigismondi, Cristina, et al.
Publicado: (2015)

Psychological Aspects Associated With Fertility Preservation in Oncology: An Exploratory Study
por: Di Mattei, Valentina Elisabetta, et al.
Publicado: (2020)

Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients
por: Arecco, Luca, et al.
Publicado: (2020)

Effect of Multiple Sclerosis and Its Treatments on Male Fertility: Cues for Future Research
por: Massarotti, Claudia, et al.
Publicado: (2021)

Reproductive Outcomes and Fertility Preservation Strategies in Women with Malignant Ovarian Germ Cell Tumors after Fertility Sparing Surgery
por: Vasta, Francesca Maria, et al.
Publicado: (2020)

Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis
por: Tagliamento, Marco, et al.
Publicado: (2021)

Identification of Psychological Profiles of Cancer Patients Undergoing Fertility Preservation Counseling
por: Di Mattei, Valentina Elisabetta, et al.
Publicado: (2023)

Effect of adding letrozole to gonadotropin on in vitro fertilization outcomes: An RCT
por: Eftekhar, Maryam, et al.
Publicado: (2020)

Assessment of Fertility Outcomes Following Combined Clomiphene and Letrozole Versus Letrozole Therapy for the Treatment of Polycystic Ovarian Syndrome Subfertility
por: Sharma, Priyanka, et al.
Publicado: (2023)

Factors Associated With a High Motivation to Undergo Fertility Preservation in Female Cancer Patients
por: Di Mattei, Valentina Elisabetta, et al.
Publicado: (2021)

The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue and the Possible Effects of Their Exogenous Inhibition
por: Scavone, Graziana, et al.
Publicado: (2023)

Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger?
por: Lalami, Imane, et al.
Publicado: (2022)

mRNA and Viral Vector COVID-19 Vaccines Do Not Affect Male Fertility: A Prospective Study
por: Massarotti, Claudia, et al.
Publicado: (2022)

The Future of Breast Cancer Research in the Survivorship Field
por: Soldato, D., et al.
Publicado: (2023)

Oncofertility counselling in premenopausal women with HER2-positive breast cancer
por: Lambertini, Matteo, et al.
Publicado: (2019)

Prognostic value of HER2-low status in breast cancer: a systematic review and meta-analysis
por: Molinelli, C., et al.
Publicado: (2023)

Contraception and Hormone Replacement Therapy in Healthy Carriers of Germline BRCA1/2 Genes Pathogenic Variants: Results from an Italian Survey
por: Massarotti, Claudia, et al.
Publicado: (2022)

Does the additional use of clomiphene citrate or letrozole for in vitro fertilization deserve more attention?
por: Liang, Ying, et al.
Publicado: (2021)

CDK4/6 inhibitors as adjuvant treatment for hormone receptor-positive, HER2-negative early breast cancer: a systematic review and meta-analysis
por: Agostinetto, E., et al.
Publicado: (2021)

Epidemiology of Clostridium Difficile Infection in a Large Hospital in Northern Italy: Questioning the Ward-Based Transmission
por: Piatti, Gabriella, et al.
Publicado: (2017)

A comparison of letrozole and anastrozole followed by letrozole in breast cancer patients
por: Aphinives, Potchavit, et al.
Publicado: (2015)

Fertility Preservation
por: Taitson, Paulo Franco, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_aj3r8hkqjeshgto65dbcqcsvuk